# OnCo record tumorapa (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/tumorapa/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "tumorapa", "NCT00133887" ;
  schema:name "TUMORAPA (switching from a calcineurin inhibitor to sirolimus after a transplant skin cancer)"@en ;
  schema:alternateName "TUMORAPA"@en, "TUMORAPA 1"@en ;
  schema:description "A person with a transplanted kidney who has had one skin squamous cancer will usually get more. Swapping one anti-rejection drug for another roughly halved the number who got another cancer, but it made people unwell often enough that a quarter stopped the new drug."@en ;
  schema:url <https://onco.cc/trials/tumorapa/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00133887>, <https://doi.org/10.1056/NEJMoa1204166>, <https://pubmed.ncbi.nlm.nih.gov/22830463/> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:technologies <https://onco.cc/technologies/chemoprevention/> ;
  onco:terms <https://onco.cc/terms/skin-cancer-after-organ-transplant/>, <https://onco.cc/pathways/field-cancerisation/> ;
  onco:trials <https://onco.cc/trials/cemiplimab-kidney-transplant-cscc/> .